Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 22 Nasopharyngeal Carcinoma 11 Squamous Cell Carcinoma of Head and Neck 9 Small Cell Lung Carcinoma 9 Uterine Cervical Neoplasms 7 Biliary Tract Neoplasms 6 Urinary Bladder Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Cholangiocarcinoma 5 Lung Neoplasms 4 Head and Neck Neoplasms 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Nasopharyngeal Neoplasms 3 Endometrial Neoplasms 3 Ovarian Neoplasms 2 Neoplasms 2 NSCLC 2 Esophageal Neoplasms 2 Breast Neoplasms 2 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Triple Negative Breast Neoplasms 1 Tongue Squamous Cell Carcinoma 1 Thyroid Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Solid Tumor Cancer 1 Recurrence 1 Rare Tumour 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1

Interventions

Temozolomide 11 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiation 3 Blood Specimen Collection 3 Bevacizumab 3 tislelizumab 2 pembrolizumab 2 cemiplimab 2 Surgical Procedures, Operative 2 mirdametinib 1 gallium maltolate 1 fluzoparib 1 florbetapir 1 elemene 1 X-Rays 1 Vortioxetine 1 Transurethral Resection of Bladder 1 Spironolactone 1 Spinal Puncture 1 Sitagliptin Phosphate 1 Sampling Studies 1 Receptors, Interleukin-8B 1 Radiotherapy, Intensity-Modulated 1 Psychosocial Intervention 1 Platinum 1 Photons 1 Photochemotherapy 1 Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Glioblastoma × Cisplatin × Clear all

NCT07138001 2025-08-22

Phase 2 Clinical Trial of KH617

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Phase 2 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡